Lilly Donations Provide Medicine for Patients in Kenya
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has donated more than $66 million in medications over the last two years to help people in western Kenya. Through the Academic Model Providing Access to Healthcare partnership, the Indiana University Center for Global Health says the donated medicines are helping Kenyans living with cancer, diabetes and mental health disorders.
IU established the AMPATH partnership with Moi University School of Medicine and Moi Teaching and Referral Hospital in Kenya more than three decades ago.
“People throughout western Kenya know about Indiana and Indiana University because of the AMPATH partnership,” IU School of Medicine Dean Jay Hess said. “Our work there, always leading with care, is helping to improve the health and wellbeing of countless Kenyans.”
The IU Center for Global Health says the donations provide Kenyans with access to medications that are limited or not available through the Ministry of Health care system.
“We are tremendously grateful for the generosity of Lilly and the Lilly Foundation, which enables IU School of Medicine physicians and their U.S. and Kenyan colleagues to dramatically improve the future for people facing serious illnesses in Africa,” said IU President Pamela Whitten.
The IU Center for Global Health says Lilly’s product donations total $215 million over the last 20 years, including a record donation of $36 million in 2021.